News Daily News Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell November 11, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
News Industry News TCT 2016 Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures November 01, 2016
News Conference News TCT 2016 Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions Michael O'Riordan October 31, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
News Daily News How PCI Mortality Is Publicly Reported Requires Reworking, ACC’s Interventional Council Says Todd Neale October 25, 2016
News Daily News The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI Todd Neale October 20, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI Michael O'Riordan October 18, 2016
News Daily News Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results Todd Neale October 03, 2016
News Features Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care Caitlin E. Cox September 23, 2016
News Daily News ¿Bivalirudina?, ¿Heparina? Una Encuesta Revela que los Médicos se Dividen por las Opciones Antitrombóticas para PCI en el Manejo de STEMI Yael L. Maxwell September 15, 2016
News Daily News Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows Yael L. Maxwell September 15, 2016
News Industry News Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease September 12, 2016
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2016 NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents? Shelley Wood August 30, 2016